Cargando…
Methylphenidate and Central Precocious Puberty: A Probable Side Effect among Seven Children with the Attention Deficit Hyperactivity Disorder
Methylphenidate (MPH) is the most preferred drug for treatment of the attention deficit hyperactivity disorder (ADHD). Here, we aimed to discuss the possible effects and mechanisms of MPH on precocious puberty (PP) via a case series with seven children who had normal body mass index. In this case se...
Autores principales: | Ergür, Ayça Törel, Gül, Hesna, Gül, Ahmet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean College of Neuropsychopharmacology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6705097/ https://www.ncbi.nlm.nih.gov/pubmed/31352713 http://dx.doi.org/10.9758/cpn.2019.17.3.446 |
Ejemplares similares
-
Factors associated with problematic internet use among children and adolescents with Attention Deficit Hyperactivity Disorder
por: Cakmak, Fatma Hulya, et al.
Publicado: (2018) -
Methylphenidate use in children with attention deficit hyperactivity disorder
por: Machado, Felipe Salles Neves, et al.
Publicado: (2015) -
The Effects of Methylphenidate on Decision Making in Attention-Deficit/Hyperactivity Disorder
por: DeVito, Elise E., et al.
Publicado: (2008) -
The Effect of Methylphenidate on the Hearing of Children with Attention Deficit Hyperactivity Disorder
por: İsmi, Onur, et al.
Publicado: (2018) -
The Association Between Attention-Deficit Hyperactivity Disorder,
Injuries, and Methylphenidate
por: Shem-Tov, Sharon, et al.
Publicado: (2019)